Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life.

Rutten-van Mölken, M P; Custers, F; van Doorslaer, E K; Jansen, C C; Heurman, L; Maesen, F P; Smeets, J J; Bommer, A M; Raaijmakers, J A

Rutten-van Mölken, M P; Custers, F; van Doorslaer, E K; Jansen, C C; Heurman, L; Maesen, F P; Smeets, J J; Bommer, A M; Raaijmakers, J A.

Affiliation

Rutten-van Mölken MP; Dept of Health Economics, University of Limburg, Maastricht, The Netherlands.

Eur Respir J ; 8(6): 888-98, 1995 Jun.

Article in En | MEDLINE | ID: mdl-7589374

Subject(s)

Albuterol/analogs & derivatives; Albuterol/therapeutic use; Asthma/drug therapy; Bronchodilator Agents/therapeutic use; Quality of Life; Sickness Impact Profile; Administration, Inhalation; Adolescent; Adult; Aged; Albuterol/administration & dosage; Bronchodilator Agents/administration & dosage; Double-Blind Method; Female; Humans; Male; Middle Aged; Reproducibility of Results; Respiratory Function Tests; Salmeterol Xinafoate; Surveys and Questionnaires

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Asthma / Bronchodilator Agents / Sickness Impact Profile / Albuterol Type of study: Clinical_trials Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Respir J Year: 1995 Document type: Article Affiliation country: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links